Hemophagocytic lymphohistiocytosis associated with dabrafenib and trametinib combination therapy following pembrolizumab administration for advanced melanoma

被引:21
|
作者
Sasaki, K. [1 ]
Uehara, J. [1 ]
Iinuma, S. [1 ]
Doi, H. [1 ]
Honma, M. [1 ]
Toki, Y. [2 ]
Ishida-Yamamoto, A. [1 ]
机构
[1] Asahikawa Med Univ, Dept Dermatol, Asahikawa, Hokkaido, Japan
[2] Asahikawa Med Univ, Dept Med, Div Gastroenterol & Hematol Oncol, Asahikawa, Hokkaido, Japan
关键词
CYTOKINE;
D O I
10.1093/annonc/mdy175
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1602 / 1603
页数:2
相关论文
共 50 条
  • [1] Hemophagocytic lymphohistiocytosis in advanced melanoma treated with dabrafenib and trametinib combination: two cases
    Samaran, Quentin
    Belakebi, Dorian
    Theret, Sarah
    Becquart, Ondine
    Girard, Celine
    Du Thanh, Aurelie
    Guillot, Bernard
    Lesage, Candice
    Dereure, Olivier
    MELANOMA RESEARCH, 2020, 30 (05) : 519 - 523
  • [2] Hemophagocytic lymphohistiocytosis associated with targeted therapy using Dabrafenib and Trametinib
    Al-Mufti, Taha
    Klein, Oliver
    Wong, ZeeWan
    Potasz, Nicole
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 : 168 - 168
  • [3] Hemophagocytic lymphohistiocytosis associated with dabrafenib and trametinib combination therapy: About two serious cases
    Theret, S.
    Ladhari, C.
    Litovsky, J.
    Baaziz, H.
    Faillie, J. L.
    Hillaire-Buys, D.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2021, 35 : 133 - 133
  • [4] Metastatic Melanoma Dabrafenib and Trametinib as Combination Therapy
    Voos, Dunja
    AKTUELLE DERMATOLOGIE, 2015, 41 (11) : 456 - 456
  • [5] Future of combination therapy with dabrafenib and trametinib in metastatic melanoma
    Zia, Yasaman
    Chen, Lawrence
    Daud, Adil
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (14) : 2257 - 2263
  • [6] Severe rhabdomyolysis developing in an advanced melanoma patient treated by pembrolizumab followed by dabrafenib trametinib combined therapy
    Irimada, Moyuka
    Fujimura, Taku
    Kambayashi, Yumi
    Tsukada, Akira
    Takahashi, Toshiya
    Hashimoto, Akira
    Aiba, Setsuya
    JOURNAL OF DERMATOLOGY, 2019, 46 (07): : E256 - E258
  • [7] Pembrolizumab associated hemophagocytic lymphohistiocytosis
    Shah, D.
    Shrestha, R.
    Ramlal, R.
    Hatton, J.
    Saeed, H.
    ANNALS OF ONCOLOGY, 2017, 28 (06) : 1403 - 1403
  • [8] Hemophagocytic lymphohistiocytosis induced by dabrafenib-trametinib in a patient with metastatic melanoma: a case report and pharmacovigilance analysis
    Elmes, Joseph B.
    Davis, Jessica M.
    Musselwhite, Laura W.
    Chiad, Zane
    Moore, Donald C.
    Amin, Asim
    MELANOMA RESEARCH, 2024, 34 (05) : 465 - 468
  • [9] Steroid refractory dermatomyositis following combination dabrafenib and trametinib therapy
    Harrison, Stephanie R.
    Tew, Alice
    Steven, Neil
    Fisher, Benjamin A.
    RHEUMATOLOGY, 2018, 57 (08) : 1497 - 1499
  • [10] Dabrafenib in combination with trametinib for the treatment of metastatic melanoma
    Awad, Mark M.
    Sullivan, Ryan J.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2015, 8 (01) : 25 - 33